Regulus

Read more
Joseph P. Hagan's photo - President & CEO of Regulus

President & CEO

Joseph P. Hagan

CEO Approval Rating

84/100

REGULUS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Dicerna is the top competitor of Regulus. Dicerna is headquartered in Lexington, Massachusetts, and was founded in 2006. Dicerna competes in the Pharmaceuticals field. Dicerna generates 1,777% the revenue of Regulus.

Regulus Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$10M

Regulus's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 63.5M. Over the last two quarters, Regulus's revenue has grown by $6K. Specifically, in Q4 2020's revenue was $5M; in Q3 2020, it was $5M.

Regulus Acquisitions

No recent acquisitions found related to Regulus

Regulus Funding History

Since Regulus was founded in 2007, it has participated in 10 rounds of funding. In total Regulus has raised $210.9M. Regulus' last funding round was on Dec 2020 for a total of $19.4M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Dec 2020
$19.4M
-
Private Placement
May 2019
$16.7M
-
Debt
Jun 2016
$30M
Equity
Feb 2014
$10M
-
Equity
Oct 2012
$25M
-

Since Regulus was founded in 2007, it has participated in 10 rounds of funding. In total Regulus has raised $210.9M. Regulus' last funding round was on Dec 2020 for a total of $19.4M

Regulus Investments

No recent investments found related to Regulus

Regulus News

May 14, 2021Markets Insider

Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit

SAN DIEGO, May 14, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical... See more »
May 7, 2021Markets Insider

Regulus Therapeutics Announces Timing for First Quarter 2021 Financial Results Webcast and Conference Call

SAN DIEGO, May 6, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical ... See more »
May 3, 2021Benzinga

Regulus Therapeutics' RGLS4326 Reports Mixed Bag On Polycystic Kidney Disease-Associated Biomarker Study

Regulus Therapeutics Inc (NASDAQ: RGLS) has announced top-line results from the first cohort of patie... See more »
April 7, 2021MarketScreener

to Present at the 20th Annual Needham Virtual Healthcare Conference

(marketscreener.com) LA JOLLA, Calif., April 7, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. , a bi... See more »
March 9, 2021BioSpace

Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and de... See more »
March 5, 2021Markets Insider

Regulus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference

LA JOLLA, Calif., March 5, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharma... See more »

Regulus Blogs

September 25, 2015REGULUS BLOG

Senior Quality Assurance Associate

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and deve... See more »
September 11, 2015REGULUS BLOG

Senior Scientist, Fibrosis and Metabolic Diseases

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and deve... See more »
September 11, 2015REGULUS BLOG

Associate Director/Director Clinical Operations

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and deve... See more »
September 1, 2015REGULUS BLOG

Senior Program Manager

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and deve... See more »
August 25, 2015REGULUS BLOG

Scientist/Senior Scientist (microRNA Biology)

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and deve... See more »
August 21, 2015REGULUS BLOG

Research Associate, Biology

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and deve... See more »
August 4, 2015REGULUS BLOG

Senior Research Associate or Scientist Oligonucleotide Chemistry

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and deve... See more »

Regulus Press Releases

May 7, 2019StreetInsider

Regulus Therapeutics Announces Closing of First Tranche of $41.8 Million Private Placement of Equity

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and de... See more »
January 7, 2019PR Newswire

Regulus Announces Clinical Candidate Nomination for the Treatment of Glioblastoma Multiforme

LA JOLLA, Calif., Jan. 7, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmac... See more »
November 19, 2018central charts

Regulus Presents Preclinical Survival Data Highlighting Potential of Novel Treatment for Glioblastoma Multiforme

LA JOLLA, Calif., Nov. 19, 2018 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharma... See more »
October 25, 2018streetinsider

Regulus to Present Data from ATHENA, a Global Natural History of Disease Study for Alport Syndrome, at ASN's Kidney Week 2018

LA JOLLA, Calif., Oct. 25, 2018 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharma... See more »
August 9, 2018PR Newswire

Regulus Reports Second Quarter 2018 Financial Results and Recent Updates

LA JOLLA, Calif., Aug. 9, 2018 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmac... See more »
March 7, 2018ForImmediateRelease

Regulus Reports Fourth Quarter and Year-end 2017 Financial Results and Pipeline Update

Travel & Tourism Industry release: LA JOLLA, Calif., March 7, 2018 /PRNewswire/ - Regulus Therapeutic... See more »
February 22, 2018ForImmediateRelease

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

Travel & Tourism Industry release: SHANGHAI, Feb. 22, 2018 /PRNewswire/ - STA Pharmaceutical Co., Ltd... See more »

Regulus Videos

August 12, 2016Regulus Vimeo Channel

"Regulus Mechanism of Action" on VIMEO

Cast: Regulus Therapeutics... See more »
April 24, 2015Regulus Vimeo Channel

"Regulus ILC 2015 v4" on VIMEO

Cast: Regulus Therapeutics... See more »

Social Media

Regulus Headquarters

10628 Science Center Drive Suite 225

San Diego, California92121

888-734-8587

Driving Directions »

Trending Companies

Regulus Summary

ABOUT

Overview

Regulus is a biopharmaceutical firm that develops and commercializes microRNA therapeutics for the treatment of inflammatory and metabolic diseases. Regulus was founded in 2007. Regulus' headquarters is located in San Diego, California, USA 92121. It ...

CEO

Regulus's President & CEO, Joseph P. Hagan, currently has an approval rating of 84%. Regulus's primary competitors are Dicerna, miRagen &

Frequently Asked Questions about Regulus

  1. When was Regulus founded?

    Regulus was founded in 2007
  2. Who is Regulus's CEO?

    Regulus's CEO is Joseph P. Hagan
  3. How much revenue does Regulus generate?

    Regulus generates $10M in revenue
  4. How much funding does Regulus have?

    Regulus has historically raised $210.9M in funding
  1. Where is Regulus's headquarters?

    Regulus's headquarters is in San Diego California, USA
  2. How many employees does Regulus have?

    Regulus has 24 employees
  3. What sector does Regulus operate in?

    Regulus is in Pharmaceuticals, Biotechnology
  4. Who are Regulus's competitors?

    Regulus's top competitors are Dicerna, miRagen